Recent

% | $
Quotes you view appear here for quick access.

Abbott Laboratories Message Board

  • rent4la rent4la Jun 25, 2013 6:27 PM Flag

    Anybody thinks we will buy Aethlon Medical (AEMD)?

    Under the feasibility study protocol, Aethlon will enroll ten end stage renal disease (ESRD) patients who are infected with the Hepatitis C virus (HCV) to demonstrate the safety of Hemopurifier therapy. Successful completion of the feasibility study will set the stage for Aethlon to conduct pivotal studies required for market clearance to treat HCV and potentially other disease conditions.

    "Obtaining FDA's permission to initiate human studies has been our most important objective for several years," stated Jim Joyce, Chairman and CEO of Aethlon Medical. "I salute the perseverance of our dedicated Aethlon team, their families, and loyal shareholders whose support allowed us to endure the challenges of navigating through FDA. We plan to reward your faith with clinical execution and progression toward a marketable therapy in the United States."

 
ABT
43.535+0.125(+0.29%)2:26 PMEDT